Surgery is not the only way to treat knee arthritis
For the many who have learned to negotiate their days around the persistent ache of knee osteoarthritis, the path forward has long seemed to end at the operating table. A procedure called Genicular Artery Embolization, now being promoted by Knee Pain Centers of America, proposes a different destination — one reached through a single outpatient visit rather than surgery. By targeting the inflamed arteries around the knee with imaging-guided precision, the technique attempts to quiet pain at its source, offering patients a meaningful pause in the long negotiation between suffering and intervention.
- Millions of osteoarthritis sufferers face a daily narrowing of possibility — stairs, chairs, and conversations all become tests of endurance that medication and injections increasingly fail to resolve.
- Knee Pain Centers of America is actively promoting GAE as a surgery-free alternative, creating new expectations among patients who have been told the operating room is their only remaining option.
- The procedure's outpatient nature and same-day discharge challenge the traditional calculus of joint care, where recovery time and surgical risk have long been the dominant costs patients weigh.
- Specialists in interventional radiology are gaining ground in a space historically owned by orthopedic surgeons, signaling a quiet but significant reshaping of who treats chronic joint pain and how.
- Whether GAE moves from a specialized offering to a standard step in the osteoarthritis treatment pathway will hinge on its performance in broader clinical use and the speed at which it becomes widely accessible.
For those living with knee osteoarthritis, daily life becomes a series of small negotiations — stairs, chairs, even standing through a conversation demand planning and endurance. The traditional answer has been to manage with medication or injections until the pain justifies surgery. Knee Pain Centers of America is now offering a different answer.
The procedure they promote, Genicular Artery Embolization, works by addressing inflammation rather than replacing the joint. An interventional radiologist uses imaging guidance to inject tiny beads into the specific arteries around the knee that are fueling the inflammatory response. Those vessels are blocked, inflammation subsides, and most patients report meaningful pain relief within days — all without a hospital stay or extended recovery.
The appeal lies in its precision and minimalism. Healthy tissue is left untouched, and the procedure is designed for patients who have already exhausted injections and medication but are not yet ready — or willing — to undergo knee replacement. Chief Medical Officer Dr. Hamid Sattar describes it as a fundamental shift in how arthritis can be managed, one that delivers real relief without surgical risk or downtime.
The centers bring together specialists from internal medicine, cardiology, and interventional radiology to build individualized treatment plans, framing their approach as both evidence-based and patient-centered. The broader significance of GAE may be what it represents: a growing medical effort to create meaningful options between conservative care and surgery, potentially extending — or eliminating — the road to the operating room for chronic joint pain sufferers.
For millions of people, knee pain has become the unwelcome constant of daily life. Climbing stairs becomes a negotiation with discomfort. Standing through a conversation at a party turns into an endurance test. The simple act of getting out of a chair requires planning. For those living with knee osteoarthritis, these moments accumulate into a narrowing of possibility—until, increasingly, they're being offered a path that doesn't lead to the operating room.
Knee Pain Centers of America has begun promoting an alternative to the traditional surgical route: a procedure called Genicular Artery Embolization, or GAE. The technique works by targeting the source of inflammation rather than replacing the joint itself. During the outpatient procedure, an interventional radiologist uses imaging guidance to inject tiny beads into the arteries surrounding the knee that are driving the inflammatory response. The beads block blood flow to those specific vessels, reducing the inflammation and, with it, the pain. Most patients report feeling improvement within days of the treatment, and the relief tends to hold.
What makes this approach distinctive is its minimalism. There is no hospital stay. There is no lengthy recovery period. The procedure happens in an outpatient setting and patients go home the same day. The technique is precise enough to treat only the arteries contributing to the problem, leaving healthy tissue untouched. For people who have already tried knee injections or medication without adequate relief, and who are hesitant about or not yet ready for knee replacement surgery, GAE offers a middle ground that has been gaining attention in interventional radiology circles.
Dr. Hamid Sattar, who serves as Chief Medical Officer at Knee Pain Centers of America, frames the procedure as a fundamental shift in how knee arthritis can be managed. "Surgery is not the only way to treat knee arthritis," he said, emphasizing that the centers' physicians are focused on delivering targeted treatments that produce real pain relief without exposing patients to surgical risks or the downtime that comes with them.
The centers position themselves as bringing together specialists from internal medicine, cardiology, and interventional radiology to build individualized treatment plans for each patient. The pitch is that care is personalized, evidence-based, and designed to help people return to activities they've had to abandon or modify because of knee pain. From the initial consultation through post-procedure follow-up, the centers describe their approach as rooted in both medical innovation and what they call compassionate care.
The emergence of procedures like GAE reflects a broader shift in how medicine is approaching chronic joint pain. Rather than viewing surgery as the inevitable endpoint for severe osteoarthritis, clinicians are developing intermediate options that can extend the period before surgery becomes necessary—or eliminate the need for it altogether. For patients who have spent years managing pain with medication or injections, the possibility of a single outpatient procedure that delivers sustained relief represents a meaningful expansion of choice. Whether GAE becomes a standard part of the treatment pathway for knee osteoarthritis, or remains a specialized option for particular patients, will likely depend on how the procedure performs in broader clinical use and how widely it becomes available.
Notable Quotes
Surgery is not the only way to treat knee arthritis. Our physicians provide innovative, targeted treatments that help patients achieve real, lasting pain relief—without the risks or downtime of surgery.— Dr. Hamid Sattar, Chief Medical Officer of Knee Pain Centers of America
The Hearth Conversation Another angle on the story
Why does a procedure like this matter now, when people have had injections and medication for years?
Because those options fail for a lot of people. You can only get so much relief from a steroid injection before it stops working, and medication has its own limits and side effects. For decades, the choice was essentially: live with it or have surgery. This sits in the middle.
But it's still an intervention—you're still putting something into the body.
True, but the difference is scale and recovery. Surgery means weeks or months of rehabilitation, physical therapy, time away from work. This is a few hours and you go home. The risk profile is completely different.
How do we know it actually works?
The source material says most patients feel improvement within days and that the relief tends to last. But that's what the centers are claiming. Real validation comes from independent clinical studies and longer-term outcome data.
Who benefits most from this?
People who are in pain but not yet ready for surgery, or who've tried everything else. People who can't afford the downtime of surgery. People who are afraid of it. It's not a replacement for surgery—it's an alternative for the people in between.
What's the catch?
The source doesn't mention cost, availability, or how many centers actually offer it. Those are the real questions. Innovation doesn't matter if it's only available in a few cities or if insurance won't cover it.